Molbio Diagnostics IPO allotment status is one of the most searched updates among investors who have applied for the company’s public issue. The Molbio Diagnostics IPO opened for subscription on August 10, 2026, and is scheduled to close on August 12, 2026. The IPO has a price band of ₹768 to ₹807 per equity share and is expected to raise around ₹940 crore.
As of August 11, 2026, the Molbio Diagnostics IPO allotment status is not available yet, because the public issue is still open for subscription. Investors will be able to check their allotment after the basis of allotment is finalized and the registrar publishes the result.
The registrar for the issue is KFin Technologies. Its official IPO allotment portal allows investors to check their application status using details such as PAN, application number or demat account information.
Molbio Diagnostics IPO Allotment Status: Latest Update
The Molbio Diagnostics IPO is currently in the subscription stage. Therefore, investors should not expect the allotment result to be available yet.
| Particular | Details |
| IPO Name | Molbio Diagnostics IPO |
| IPO Type | Mainboard |
| IPO Open Date | August 10, 2026 |
| IPO Close Date | August 12, 2026 |
| Price Band | ₹768–₹807 per share |
| IPO Size | Around ₹940 crore |
| Fresh Issue | ₹200 crore |
| Offer for Sale | Around ₹740 crore |
| Registrar | KFin Technologies |
| Allotment Status | Not announced yet |
| Listing Status | Not announced yet |
When Will Molbio Diagnostics IPO Allotment Status Be Available?
The allotment status can only be checked after the IPO subscription period ends and the basis of allotment is finalized.
Since the Molbio Diagnostics IPO closes on August 12, 2026, investors should wait for the official allotment process to be completed. The exact allotment date should be confirmed through the issue’s official documents and registrar once published.
At present, an officially confirmed allotment date was not available in the sources checked. Therefore, investors should avoid relying on unofficial dates circulating online.
Once the allotment is finalized, investors can use their PAN, application number or demat account details to check whether shares have been allotted.
How to Check Molbio Diagnostics IPO Allotment Status Online
Investors can check the Molbio Diagnostics IPO allotment status through the registrar’s website once the result is published.
KFin Technologies provides an online IPO allotment facility where applicants can select the relevant IPO and enter their application details. The portal supports checks using application number, demat account or PAN.
Check Molbio Diagnostics IPO Allotment on KFin Technologies
Follow these steps:
- Visit the KFin Technologies IPO allotment status portal.
- Select Molbio Diagnostics IPO from the available IPO list once it is added.
- Choose the relevant search option, such as PAN, application number or demat account.
- Enter the required details.
- Complete the verification shown on the page.
- Submit the information.
- Your Molbio Diagnostics IPO allotment status will be displayed if the result has been released.
What Details Are Required to Check Molbio Diagnostics IPO Allotment?
Investors generally need one of the following details to check their IPO allotment:
- PAN number
- IPO application number
- Demat account details
KFin Technologies’ allotment portal specifically provides these options for checking IPO application status.
It is advisable to keep the same details used while submitting the IPO application ready. This makes the checking process quicker once the allotment result becomes available.
Molbio Diagnostics IPO Allotment Through PAN
Checking the allotment using PAN is one of the simplest options for investors.
Once the registrar publishes the allotment data, investors can select the PAN option on the KFin Technologies portal and enter their PAN details. The system will then show the relevant application result.
If shares have been allotted, the result will indicate the number of shares allocated to the applicant. If the application is unsuccessful, the status will reflect that no shares were allotted.
Investors should remember that the allotment result is different from the IPO subscription status. Subscription data shows demand during the issue period, while allotment confirms the shares actually assigned to an applicant.
Molbio Diagnostics IPO Allotment Through Application Number
Applicants can also check their allotment using the IPO application number.
The application number is provided when an investor submits an IPO application. Entering the correct application details on the registrar’s portal can help retrieve the allotment result after it is finalized.
Investors should enter the details carefully because an incorrect application number may prevent the system from finding the application.
What Happens After Molbio Diagnostics IPO Allotment?
The process does not end when the allotment result is published. After allotment, several steps take place before the shares begin trading on the stock exchanges.
If an investor receives an allotment, the allotted shares are credited to the investor’s demat account according to the issue timeline.
For applicants who do not receive an allotment, the blocked application amount is released according to the applicable IPO process.The next important event for successful applicants is the credit of shares and subsequent listing of Molbio Diagnostics shares on the stock exchanges.
The exact dates for these steps should be taken from the final issue schedule published by the company, stock exchanges or registrar.
Key Details
Molbio Diagnostics is a Goa-based molecular diagnostics company known for its point-of-care diagnostic solutions and Truenat platform. The company was incorporated in 2000 and operates in the molecular diagnostics segment.
The IPO consists of a ₹200 crore fresh issue and an offer for sale of existing shares. The company plans to use the fresh issue proceeds for purposes including capital expenditure and strengthening its operations.
The IPO has also attracted anchor investors. Reports indicate that the company raised ₹281 crore from anchor investors before the public issue opened, with participation from investors including the International Finance Corporation and HDFC Asset Management Company.
Molbio Diagnostics IPO GMP and Allotment Status
Molbio Diagnostics IPO GMP, or Grey Market Premium, has attracted considerable attention during the IPO period.
Recent market reports have indicated a positive grey market premium. However, GMP is an unofficial market indicator and should not be treated as a guarantee of the IPO’s listing price or future performance.
As of August 10, reports indicated a GMP of around ₹807, although grey market figures can change quickly.
Investors should therefore consider GMP alongside the company’s financial performance, valuation, business prospects and risks rather than relying on GMP alone.
Molbio Diagnostics IPO Subscription Status
The subscription status is another important factor to monitor before the allotment.
The IPO opened on August 10 and will remain open until August 12, 2026. Investors can follow category-wise subscription figures during the issue period to understand the level of demand from retail investors, qualified institutional buyers and non-institutional investors.
However, subscription figures should not be confused with allotment. A highly subscribed category can make allotment more competitive, particularly for retail applicants, but the final allocation is determined according to the applicable IPO allotment process.
Why Is Molbio Diagnostics IPO Allotment Status Important?
The allotment status tells an applicant whether shares have actually been assigned against the IPO application.
This is particularly important when an IPO receives strong demand. An investor may successfully submit an application but still receive fewer shares than applied for or no shares at all, depending on the applicable allocation process and demand in the relevant category.
Therefore, checking the allotment status is the most reliable way to know the outcome of an individual application.
Frequently Asked Questions
No. As of August 11, 2026, the allotment status is not available because the IPO is still open for subscription. The issue is scheduled to close on August 12, 2026.
You can check the allotment status through KFin Technologies, the registrar of the issue, once the allotment result is published. The registrar’s portal supports PAN, application number and demat account-based searches.
Investors can use their PAN, IPO application number or demat account details to check the allotment status through the registrar’s portal.
The IPO closes on August 12, 2026. The final allotment will be announced after the issue closes and the basis of allotment is finalized. The exact confirmed allotment date was not publicly available in the sources checked at the time of writing.
If shares are not allotted, the amount blocked for the IPO application is released according to the applicable IPO process. Investors should check their bank or UPI mandate status and application details if the release does not occur within the prescribed timeline.
Conclusion
The Molbio Diagnostics IPO allotment status is not available yet as of August 11, 2026, because the public issue is still open and is scheduled to close on August 12.
Once the allotment process is completed, investors can check their individual application result through KFin Technologies using their PAN, application number or demat account details.
For the latest updates, investors should also track the Molbio Diagnostics IPO subscription status, GMP and listing schedule. Most importantly, rely on the official registrar and exchange information when checking the final allotment result rather than unverified social media updates.
Add a Comment